Related Experiment Video
Updated: May 5, 2026
06:16
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
5.8K
Optimizing the design of pragmatic trials: key issues remain
1United BioSource Corporation, Lexington, MA, USA and Montreal, PQ, Canada;430 Bedford Street, Suite 300, Lexington, MA 02420, USA.
Journal of Comparative Effectiveness Research
|November 19, 2013
Summary
Clinical trials often show benefits that don't last in real-world practice. This paper discusses challenges in designing pragmatic trials to ensure findings are applicable and reliable for decision-making.
Area of Science:
- Clinical Research Methodology
- Evidence-Based Practice
Background:
- Traditional clinical trials prioritize maximizing intervention effects, often limiting real-world applicability.
- Observed treatment benefits in controlled settings frequently diminish in routine care.
- A gap exists in reliable evidence for decision-making in clinical practice.
Purpose of the Study:
- To review challenges in designing pragmatic trials.
- To highlight design aspects requiring a pragmatic approach for real-world applicability.
- To improve the reliability of evidence for clinical decision-making.
Main Methods:
- Review of challenges in pragmatic trial design.
- Analysis of design features impacting real-world applicability.
- Discussion of bias minimization in pragmatic research.
Main Results:
- Pragmatic trials aim to enhance the generalizability of findings to routine practice.
- Minimizing design features that limit applicability is key in pragmatic trials.
- Addressing biases remains a significant challenge in pragmatic trial design.
Conclusions:
- Pragmatic trial design is crucial for bridging the gap between research and practice.
- A pragmatic approach to design is essential for generating applicable and reliable evidence.
- Careful consideration of design aspects is needed to overcome challenges in pragmatic trials.
More Related Videos
Related Concept Videos
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
422
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
422
01:28Methods of Medium Optimization
74
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
74
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
01:16Experimental Designs
11.3K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
11.3K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631